Modern Diagnostic & Research Centre Limited IPO Details
SME
Modern Diagnostic & Research Centre IPO DRHP (Draft Red Herring Prospectus) has been Exchange Approval Received.
Modern Diagnostic & Research Centre IPO total issue size comprises 41,00,000 shares . This includes a fresh issue of 41,00,000 shares .
The Lead Managers for Modern Diagnostic & Research Centre IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Beeline Capital Advisors Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Modern Diagnostic & Research Centre Limited DRHP.
Modern Diagnostic & Research Centre IPO Details
Modern Diagnostic & Research Centre IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
To be announced |
Modern Diagnostic & Research Centre IPO Reservation
Promoter Holding
Documents
Modern Diagnostic & Research Centre IPO Valuations
Modern Diagnostic & Research Centre Financial Information
Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 57.79 | 49.49 | 36.54 | 48.7 |
Revenue | 40.33 | 68.67 | 56.61 | 60.58 |
Profit After Tax | 4.96 | 5.79 | -5.73 | -1.45 |
Net Worth | 16.71 | 11.76 | 5.96 | 11.7 |
Reserves and Surplus | 15.71 | 10.76 | 4.96 | 10.7 |
Total Borrowing | 21.13 | 20.46 | 15.31 | 20.4 |
Amount in ₹ Crore |
About Modern Diagnostic & Research Centre IPO
Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.
The company provides reliable diagnostic tests, home specimen collection, online reports, and customized test packages for institutional customers and patients based on their specific needs.
The company operates 21 centers (17 labs, 4 diagnostic centers) across 8 states, offering diagnostic services like ultrasound, CT, MRI, X-ray, ECG, PFT, and specialized labs for heart and neuro care.
Services:
- Pathology:MDRC provides a wide array of tests, including high-end molecular diagnostics, cytogenetics, and specialized panels for genetic disorders and cancer.
- Radiology:The centre offers advanced imaging services such as MRI, CT scans, ultrasound, and digital X-rays, utilizing state-of-the-art equipment like a 3-Tesla MRI machine and a 128-slice CT scanner.
- Home Sample Collection:MDRC offers home blood sample collection services in several cities, providing convenience for patients unable to visit the centre.
As on February 28, 2025, the company has total 570 Employees including Consultants and doctors.
Strength Of Modern Diagnostic & Research Centre IPO
Risk Of Modern Diagnostic & Research Centre IPO
Objectives Modern Diagnostic & Research Centre IPO
1. Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories
2. Funding Working Capital Requirement
3. Repayment of certain outstanding borrowings availed by the Company
4. General Corporate Expenses
Company Contact Details
Modern Diagnostic & Research Centre Limited
Plot No H-64,1st Floor BLK-H,
Bali Nagar City landmark near Khetar Pal Hospital,
Ramesh Nagar, West Delhi, New Delhi
Phone: 9999474297
Email: compliance@mdrcindia.com
Website: http://www.mdrcindia.com/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Market Maker
To be announced
Read more about Shringar House of Mangalsutra IPO
- Modern Diagnostic & Research Centre Limited IPO Detail
- Modern Diagnostic & Research Centre Limited IPO Subscription Detail
- Modern Diagnostic & Research Centre Limited IPO GMP Detail
- Checked Live Modern Diagnostic & Research Centre Limited IPO Allotment Status
- Modern Diagnostic & Research Centre Limited IPO Basis Of Allotment
- Modern Diagnostic & Research Centre Limited IPO Price Calculator
- Modern Diagnostic & Research Centre Limited IPO Stock Price